VETOQUINOL SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.6 EUR | +1.63% |
|
+3.64% | -2.73% |
| Mar. 20 | Vetoquinol SA Proposes Dividend | CI |
| Mar. 20 | Vetoquinol SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 602.3 | 762.5 | 989.1 | 1,561 | 1,036 | 1,178 | 1,178 | - |
| Enterprise Value (EV) 1 | 491.3 | 690.1 | 972.1 | 1,507 | 959.9 | 1,082 | 994.8 | 943 |
| P/E ratio | 16.5 x | 26.6 x | 51.3 x | 24.8 x | 21.6 x | 21.4 x | 20.7 x | 19.2 x |
| Yield | 0.94% | 0.75% | 0.6% | 0.61% | 0.91% | 0.83% | 0.82% | 0.85% |
| Capitalization / Revenue | 1.64 x | 1.93 x | 2.31 x | 2.99 x | - | 2.29 x | 2.13 x | 2.04 x |
| EV / Revenue | 1.34 x | 1.74 x | 2.27 x | 2.89 x | - | 2.04 x | 1.8 x | 1.63 x |
| EV / EBITDA | 8.13 x | 10.6 x | 11.6 x | 12.6 x | 8.13 x | 9.57 x | 8.87 x | 7.9 x |
| EV / FCF | 20.8 x | 18.3 x | 11.9 x | 19.9 x | 20.9 x | 12.2 x | 15.6 x | 13.8 x |
| FCF Yield | 4.82% | 5.46% | 8.42% | 5.03% | 4.78% | 8.23% | 6.42% | 7.24% |
| Price to Book | 1.66 x | 1.98 x | 2.67 x | 3.54 x | 2.14 x | 2.22 x | 2.04 x | 1.87 x |
| Nbr of stocks (in thousands) | 11,856 | 11,841 | 11,832 | 11,826 | 11,829 | 11,832 | 11,832 | - |
| Reference price 2 | 50.80 | 64.40 | 83.60 | 132.0 | 87.60 | 99.60 | 99.60 | 99.60 |
| Announcement Date | 3/20/19 | 3/26/20 | 4/1/21 | 3/24/22 | 3/23/23 | 3/20/24 | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 367.9 | 396 | 427.5 | 521.3 | - | 529.3 | 552.7 | 577.7 |
| EBITDA 1 | 60.4 | 65.4 | 83.9 | 119.3 | 118 | 113 | 112.2 | 119.4 |
| EBIT 1 | 48.4 | 45.9 | 56.2 | 86.7 | 84.6 | 71.6 | 79.32 | 86.04 |
| Operating Margin | 13.16% | 11.59% | 13.15% | 16.63% | - | 13.53% | 14.35% | 14.89% |
| Earnings before Tax (EBT) 1 | 48.58 | - | 35.58 | 86.5 | 72.7 | 79 | 80.7 | 89.15 |
| Net income 1 | 36.3 | 28.2 | 18.9 | 62.9 | 48 | 55.6 | 56.94 | 61.38 |
| Net margin | 9.87% | 7.12% | 4.42% | 12.07% | - | 10.5% | 10.3% | 10.62% |
| EPS 2 | 3.070 | 2.420 | 1.630 | 5.330 | 4.060 | 4.654 | 4.814 | 5.178 |
| Free Cash Flow 1 | 23.66 | 37.69 | 81.89 | 75.9 | 45.88 | 89 | 63.84 | 68.28 |
| FCF margin | 6.43% | 9.52% | 19.16% | 14.56% | - | 16.81% | 11.55% | 11.82% |
| FCF Conversion (EBITDA) | 39.18% | 57.63% | 97.61% | 63.62% | 38.88% | 78.76% | 56.89% | 57.18% |
| FCF Conversion (Net income) | 65.19% | 133.66% | 433.3% | 120.66% | 95.59% | 160.07% | 112.12% | 111.24% |
| Dividend per Share 2 | 0.4800 | 0.4800 | 0.5000 | 0.8000 | 0.8000 | 0.8500 | 0.8160 | 0.8450 |
| Announcement Date | 3/20/19 | 3/26/20 | 4/1/21 | 3/24/22 | 3/23/23 | 3/20/24 | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S1 | 2020 S1 | 2021 Q1 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 183.8 | 196.1 | 127.6 | 127.4 | 255 | 132.3 | 133.7 | 136 | 271 | 134 | 135 | 145 | 110.8 | 256.2 | 135.8 | 137 | 146 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT | 17.9 | 25.3 | - | - | 50.4 | - | - | - | - | - | - | - | - | 45.42 | - | - | - |
| Operating Margin | 9.74% | 12.9% | - | - | 19.76% | - | - | - | - | - | - | - | - | 17.73% | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 7/25/19 | 7/30/20 | 4/29/21 | 7/29/21 | 7/29/21 | 10/14/21 | 3/24/22 | 7/20/22 | 7/20/22 | 10/13/22 | 3/23/23 | 4/19/23 | 9/7/23 | 9/7/23 | 10/26/23 | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 111 | 72.4 | 17 | 53.6 | 76.3 | 130 | 184 | 235 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 23.7 | 37.7 | 81.9 | 75.9 | 45.9 | 89 | 63.8 | 68.3 |
| ROE (net income / shareholders' equity) | 10.4% | 7.53% | 7.75% | 15.5% | 10.4% | 10.7% | 10.2% | 9.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | 8.24% | 7.2% | 6.6% | 6.7% |
| Assets 1 | - | - | - | - | 582.3 | 759.2 | 862.7 | 916.1 |
| Book Value Per Share 2 | 30.70 | 32.50 | 31.30 | 37.30 | 41.00 | 44.80 | 48.80 | 53.20 |
| Cash Flow per Share 2 | 3.200 | 4.400 | 7.800 | 7.580 | 5.310 | 7.420 | 7.740 | 7.930 |
| Capex 1 | 14.2 | 14.3 | 10.3 | 13.8 | 17 | 20 | 18.7 | 19.7 |
| Capex / Sales | 3.86% | 3.62% | 2.42% | 2.65% | - | 3.76% | 3.38% | 3.41% |
| Announcement Date | 3/20/19 | 3/26/20 | 4/1/21 | 3/24/22 | 3/23/23 | 3/20/24 | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
99.6
EUR
Average target price
108.4
EUR
Spread / Average Target
+8.85%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -2.73% | 1.26B | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -2.92% | 3.12B | |
| -0.68% | 1.4B | |
| -17.27% | 1.34B | |
| -14.67% | 1.12B | |
| -5.37% | 990M | |
| -24.06% | 805M |
- Stock Market
- Equities
- VETO Stock
- Financials Vetoquinol SA
